Senators offered the US Food and Drug Administration less funding for fiscal year 2022, along with an alternative direction on facility inspections, compared to their colleagues in the House of Representatives.
The Senate Agriculture, Rural Development, FDA and Related Agencies appropriations bill, which was sent to the floor on 4...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?